Biovail Announces Annual and Special Meeting of Shareholders.TORONTO -- Biovail Corporation (NYSE NYSE See: New York Stock Exchange : BVF BVF Biovail Corporation (stock symbol) BVF Berufsverband der Frauenärzte eV (Muenchen, Germany) BVF Bearing Versus Frequency )(TSX TSX Toronto Stock Exchange (TSE before April, 2002) TSX Transfer from Stack Pointer to Index TSX True Space Extension : BVF) announced today that its Board of Directors has called an annual and special meeting of the shareholders to be held in Toronto, Ontario on May 28, 2009. In addition to ordinary annual meeting matters and matters to be put forth by Biovail, the meeting will also consider the matters raised in the February 25, 2009 requisition from Eugene Melnyk Eugene Melnyk (born May 27, 1959 in Toronto, Ontario) is a Canadian businessman of Ukrainian origin who now resides in Barbados. He is the chairman and chief executive officer of Biovail Corporation. and a company under his control, EM Holdings B.V. The record date for determining those shareholders entitled to receive notice of the meeting is April 20, 2009. Formal notice of the meeting and Biovail's management proxy circular will be sent to Biovail shareholders in due course. About Biovail Corporation Biovail Corporation is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture, and commercialization of pharmaceutical products. The Company is focused on the development and commercialization of medicines that address unmet medical needs in niche specialty central nervous system (CNS See Continuous net settlement. CNS See continuous net settlement (CNS). ) markets. For more information about Biovail, visit the Company's Web site at www.biovail.com. For further information, please contact Nelson F. Isabel at 905-286-3000 or send inquiries to ir@biovail.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion